2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92547°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
SKÅÚ·¹ÄÞ ¿ÀÇ Ŀ¹Â´ÏÄÉÀÌ¼Ç ¼­ºñ½º ¡®ÄݽÌÅ©¡¯ (2016-11-27)
Çѹ̾àǰ °ËÂû°í¹ß, °ø½Ã±ÔÁ¤ °³Á¤ ½Ã±Þ (2016-10-05)
Á÷ÀåÀΠü°¨ ÅðÁ÷¿¬·É ¡®51.7¼¼¡® (2017-04-17)
VRµ¿¿µ»ó Ç÷¹ÀÌ¾î ¡®NVR Player¡¯ ½ºÆÀ Ç÷§Æû (2018-03-27)
ÀÌÃ¢ÈÆ, ¡®´ëÇà»ç¡¯ ÇѺ´¼ö ±× ÀÚüÀÎ ºñÇÏÀεå (2023-01-29)
¹«´õÀ§¿¡ LG ³Ãµ¿°í ÆÇ¸Å 20% ÀÌ»ó Áõ°¡ (2016-08-26)
Â÷¼±¼ö, ¾ÖÇÁÅ͸¶ÄÏ ¼­ºñ½º·Î ¼Ò»ó°øÀÎ Áö¿ø (2016-12-01)
10°³ ±×·ì, ÀÏ¹Ý Ã¤¿ëÀüÇü°ú ½ºÆåŸÆÄ ä¿ëÀüÇü (2015-12-14)
ÆóÇÃ¶ó½ºÆ½ Á¤Á¦¿­ºÐÇØÀ¯ ¹ßÀü¿¬·á Ȱ¿ë ¹× ±â¼ú °³¹ß (2023-10-03)
McAfee and Samsung Extend Partnership for 10th Year, Expand ... (2024-07-29)
½Ã¸®¾Æ ºÐÀï, Á¢±Ù ºÒ°¡´ÉÇØ ÀÇ·á ±¸È£ ¸¶ºñ (2015-03-11)
·°¼Å¸® °¡½À±â ¡®HM-C610S¡¯ (2016-01-05)
20´ë ¼ÒºñÀÚ, ¡®°¡¼ººñ¡¯º¸´Ù ¡®³» ÃëÇ⡯ÀÌ ´õ Áß¿ä (2017-06-13)
¸ð¹ÙÀÏ °ÔÀÓÇÏ´Â Á÷ÀåÀÎ 61% ¡®ÇöÁú¡¯ (2017-03-25)
¼º³²½Ã Áö´ÉÇü±³Åëü°è ±¸Ãà »ç¾÷¿¡ ¡®ConnecTome¡¯ µµÀÔ (2024-04-14)
È­Àåǰ »ê¾÷, ¹Ì·¡¼ºÀ嵿·ÂÀ¸·Î Áö¿ø¹Þ´Â´Ù (2017-02-22)
¾ß»ý½Ä¹° ´ë·®Áõ½Ä À§ÇÑ ¡®¹ÙÀÌ¿À¿¬±¸Áö¿ø¼¾ÅÍ¡¯ Âø°ø (2017-11-27)
GS25, ¹°°¡ ¾ÈÁ¤ PB¿ë±â¸é ¡®À¯¾î½º¸é¿Õ¡¯ Ãâ½Ã (2023-12-08)
MSCI Announces Results of the MSCI 2024 Market Classificatio... (2024-06-28)
´õ¹Ùµð¼¥, ¡®À£´Ï½º¡¯ Ãâ½Ã (2022-09-05)
¿Ã »ó¹Ý±â Á÷±Þº° ä¿ë°ø°í »ç¿ø±ÞÀÌ 64.1% (2017-08-04)
SKÅÚ·¹ÄÞ, ÃÊ´ë¿ë·® À¯¼±¸Á µµÀÔÀ¸·Î 6G ½Ã´ë Áغñ ¼Óµµ (2023-10-16)
¹è¿ì ±èÁÖ¸®, ¼¿Ä«...'ÀÎÇü ¹Ì¸ð °ú½Ã' (2015-08-11)
¿¬±¸ °³¹ß 7´ë ºÐ¾ß ±â¼ú ¼öÁØ¡¦¹Ì±¹ÀÇ ¾à 83% (2016-03-14)
Çѱ¹°æÁ¦, °Ç¼³ÅõÀÚ ÀÇÁ¸Çü °æÁ¦ ±¸Á¶°¡ ¹®Á¦ (2017-07-30)
       [ÀÌÀü][1]....[1202][1203][1204][1205][1206][1207][1208][1209][1210]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..